Tag Archives: chief-executive

Biz Break: SunPower shines with new solar panel technology deal – The Mercury News

Posted: February 22, 2017 at 4:04 am

Top of the Order:

Here Comes the SunPower:With the way the weather has been around the region lately, and more rain coming down everywhere, the sun shining in the clear blue sky has been as rare as a day without the soul-crushing gridlock along our parking lot-like freeways.

But, all the clouds and the rain couldnt dampen the enthusiasm that greeted San Jose-based SunPower after thesolar-technology company signed a deal to provide solar-panel technology to the Cajon Valley Unified School District near San Diego. SunPower investors liked the thought of the company going back to school so much, so to speak, that they sent SunPower shares up 8.8 percent to close Tuesday at $8.58.

All in all, signing up a school district near San Diego isnt that big of a deal. However, with the solar-panel market seen as being in a bit of a holding pattern for now, SunPowers new deal suggests the company is still able to sign contracts, and that there is growing confidence in its technology. The company is viewed as setting itself up for 2018, when the solar-panel industry is expected to turn around and grow, again.

So, in spite of all the rain right now, SunPower is finding a way to shine.

Middle Innings:

The Old Boss is Back, In a Way: Chances are that late last week, you focused your attention on what you were going to do during the three-day Presidents Day holiday weekend. For me, it was spending the time up at Yosemite celebrating the latest anniversary of my 29th birthday with my family and some friends.

So, no one would blame you for missing that former Cypress Semiconductor Chief Executive T.J. Rodgers decided to sue the company he founded, and led for more than three decades.

Rodgers said he was suing Cypress in order to obtain books and records related to what he called irreconcilable conflicts of interest involving the semiconductor companys executive chairman, Ray Bingham. In a statement, Rodgers cited Binghams ties to Canyon Bridge Equity Partners a private equity firm Rodgers said is backed by the government of the Peoples Republic of China and which is attempting to buy chipmaker Lattice Semiconductor as evidence that Bingham may not be acting in Cypress best interests.

Canyon Bridges pending $1.3 billion acquisition of U.S. programmable logic maker Lattice Semiconductor, a company Cypress has attempted to acquire on two previous occasions, clearly demonstrates that Canyon Bridge competes directly with Cypress, Rodgers said in a statement. As Cypresss Executive Chairman, Ray Bingham has intimate knowledge of the Companys M&A (mergers and acquisition) strategy and Rodgers believes that Bingham can use that knowledge to benefit Canyon Bridge to the detriment of the Company and its stockholders.

Rodgers is more than just an angry ex-boss who is shaking his fist at the place where he used to work. When he retired as CEO last year, Rodgers had been the only chief executive Cypress ever had since Rodgers founded the company in 1982. And with more than 8.6 million shares of Cypress stock, Rodgers remains the companys single-largest individual shareholder, so his opinions are likely to have some impact with Cypress other stock owners.

Rodgers also said he was nominatingDaniel McCranie and Camillo Martino for Cypress board of directors. McCranie is chairman of On Semiconductor, while Martino is on the board of directors of MagnaChip Semiconductor. Rodgers said he would send out McCranies and Martinos names as part of a proxy statement to Cypress shareholders who will be able to vote for the nominees at Cypress next annual meeting.

Bottom of the Lineup:

Heres a look at how some leading Silicon Valley stocks did Tuesday.

Movin on Up:In addition to SunPower, gains came from Coupa Software, Advanced Micro Devices, Finisar and Extreme Networks.

In the Red:Decliners included Quotient Technology, Depomed, Pandora Media, TiVo and Shutterfly.

The tech-focusedNasdaq Composite Indexrose 0.5 percent to 5,865.95.

The blue chipDow Jones Industrial Averageadded 0.6 percent to end the day at 20,743.

And the broad-basedStandard & Poors 500 Indexalso rose 0.6 percent to finish at 2,365.38.

Quote of the Day:I would be wrong to allow my poor choice of words to detract from my colleagues important reporting, so today I am resigning from Breitbart, effective immediately. This decision is mine alone. Conservative provocateur Milo Yiannapoulous, who resigned his editor position at Breitbart amid a controversy over comments he had made related to pedophilia.

Sign up for the 60-Second Business Break newsletter atwww.siliconvalley.com.

See the rest here:

Biz Break: SunPower shines with new solar panel technology deal – The Mercury News

Posted in Technology | Comments Off on Biz Break: SunPower shines with new solar panel technology deal – The Mercury News

Trump’s Plan to Tap Offshore Profit for Infrastructure Gains an Ally … – Bloomberg

Posted: February 9, 2017 at 6:36 am

President Donald Trumps plan to use corporate profits returned from overseas to help finance nationwide improvements to roads, bridges, airports and other public works picked up an important supporter in the U.S. House: Representative Bill Shuster.

The dollars are out there, so we get a piece of that, Shuster, a Pennsylvania Republican who chairs the House Transportation and Infrastructure Committee, said in an interview. The process of returning corporate profit to the U.S., known as repatriation, can be one of the sources that helps generate funding for repairs and new construction, he said.

Photographer: Andrew Harrer/Bloomberg

Trump has proposed spending $1 trillion during the next decade on U.S. infrastructure and wants to leverage more private-sector dollars. Gary Cohn, Trumps chief economic adviser, said on Fox Business on Feb. 3 that the president wants to use proceeds from repatriation to help fund the improvements.

U.S. companies have an estimated $2.6 trillion in profits that theyve earned overseas and are keeping there. Under federal tax law, offshore earnings arent taxable in the U.S. until companies decide to return the income to America. Trump and House Republicans have called for establishing a lower tax rate on those profits, easing their return to the U.S.

But theres been less agreement about how to use the resulting tax revenue. Shuster said he expects a lot of it would be used to offset broader tax-rate cuts, as House Republican leaders have proposed. What exactly is the funding, thats what were going to try to figure out and debate and move, Shuster said. Everythings going to be on the table.

Democrats have said theyre willing to work with Trump on infrastructure, including in the Senate, where lawmakers have proposed spending $1 trillion during the next 10 years. Republican congressional leaders, however, are pushing for private investment to play a bigger role. Republican House Speaker Paul Ryan has said he would like to see $40 in private spending for every additional federal dollar.

Asked whether Ryan supports using repatriation for infrastructure, spokeswoman AshLee Strong said only that congressional leaders will work with the Trump administration to craft a fiscally responsible infrastructure plan.

Witnesses at the first hearing of the House Transportation and Infrastructure Committee last week, including FedEx Corp. Chairman and Chief Executive Officer Frederick Smith, said they dont think additional private-sector funding will be enough to meet the nationwide need. They said additional federal spending, from a gas tax that hasnt been increased since 1993 or other sources, must be included.

Shuster said a combination of additional federal spending and increased private investment will be needed but said he couldnt provide the precise mix. Asked whether hed support increasing the gas tax, Shuster didnt rule it out as part of negotiations to get a final package.

That is certainly a difficult thing to do, he said. Its something we should look at and consider.

One thing he cant support: creating a federal infrastructure bank to provide funding for projects, Shuster said. Senate Democrats and Steve Mnuchin, Trumps choice to be Treasury secretary, have floated that concept, but Shuster said he feared it would become a boondoggle in Washington.

Its also important that whatever infrastructure package emerges be done in cooperation with U.S. states, Shuster said.

You have to have the states buy-in to this infrastructure bill and what they want to do, he said.

Keep up with the best of Bloomberg Politics.

Get our newsletter daily.

Its also likely that infrastructure could help get Democrats to accept changes they may not want on taxes and health care, Shuster said.

As we go through Obamacare and tax reform, for the Democrats, theres some bitter pills that they may have to swallow, Shuster said. And the sweet chaser is infrastructure dollars.

Originally posted here:

Trump’s Plan to Tap Offshore Profit for Infrastructure Gains an Ally … – Bloomberg

Posted in Offshore | Comments Off on Trump’s Plan to Tap Offshore Profit for Infrastructure Gains an Ally … – Bloomberg

Panera surges to record as Wall Street eyes payoff from technology – Reuters

Posted: at 6:05 am

SAN FRANCISCO Shares of Panera Bread (PNRA.O) surged to a record high on Wednesday and were on track for the biggest one-day move in almost two years after the company gave an upbeat forecast and said technology investments at its restaurants were paying off.

The St. Louis, Missouri-based company late on Tuesday reported quarterly results above Wall Street’s expectations and offered a strong outlook for 2017. Its stock on Wednesday jumped as much as 9.6 percent before paring gains to trade up 8.3 percent.

Recent investments to add ordering kiosks and other technology upgrades to Panera’s retail locations are beginning to show results, company founder and Chief Executive Ron Shaich told analysts on a conference call late on Tuesday.

Such changes may help offset rising labor costs – driven by rising minimum wages and declining unemployment – that have hurt the profits of many restaurant chains.

Following the lead of Domino’s Pizza (DPZ.N) and other pizza chains that have successfully used smartphone apps to drive growth, Panera said a quarter of its sales are now online.

Panera last month said it completed a goal of removing artificial ingredients, which are federally approved, from its menus in U.S. restaurants, in response to customer desire for foods they believe are healthier.

“Panera has really staked its claim on trying to get rid of artificial ingredients,” said Maxim analyst Stephen Anderson. “That’s been the halo they’ve had, and they’ve been able to gain share.”

Panera has won attention from mutual fund managers. Seventy-five mutual funds disclosed that they were new owners of the stock in recent quarterly filings, compared with 50 mutual funds that sold all their Panera shares, according to Morningstar.

Panera’s stock is up 13 percent so far in 2017, compared with a 7 percent increase in rival Chipotle Mexican Grill (CMG.N), which is trying to win back diners after a series of food safety lapses.

(Reporting by Noel Randewich; Editing by Leslie Adler)

SINGAPORE/PARIS Singapore Airlines (SIA) announced a $13.8 billion order to buy 39 Boeing wide-body aircraft as it pursues expansion opportunities, a setback for the U.S. planemaker’s rival Airbus Group in the fight for long-term orders.

NEW YORK/LONDON Goldman Sachs Investment Partners (GSIP), which opened in 2008 with one of the biggest launches in hedge fund history, is folding its London operations into the United States and shifting staff members to New York, four sources told Reuters.

BEIJING China vehicle sales in January fell by the largest margin since 2015 for several global automakers, with General Motors Co and Ford Motor Co blaming the roll back of a tax cut on small-engined vehicles and the Lunar New Year holiday.

See the original post here:

Panera surges to record as Wall Street eyes payoff from technology – Reuters

Posted in Technology | Comments Off on Panera surges to record as Wall Street eyes payoff from technology – Reuters

Executive Team | www.extropy.com

Posted: October 1, 2016 at 1:48 am

Nicholas Montera – Chief Executive Officer (CEO) and Managing Partner

Nicholas is one of the founding members of Extropy and is a leading information technology expert with extensive experience involving large-scale IT initiatives. In his role as CEO Nicholas has developed Extropys strategic approach and focused its efforts to provide world class professional services and solutions. His vision is for Extropy to recruit and cultivate the best talent in the industry expanding Extropys “tribal knowledge” base to deliver innovative solutions founded in deep experience and due diligence. As the Chief Executive Officer of Extropy, he provides leadership to the executive management team; ensuring that the company is focused on the mission and our actions are in alignment with our core values. Nicholas has been deeply involved throughout his career in information technology planning, sales and engagement management. He came to form Extropy after successful careers with both British Telecom and Avaya. Nicholas attended the Florida Institute of Technology studying Mechanical Engineering and Business Administration. He also holds the industries highest networking certification, Cisco Certified Internetworking Expert, (CCIE #11811).

Brett Coover – Chief Technology Officer (CTO) and Managing Partner

Brett is one of the founding members of Extropy and is a thought leader in solutions across many technologies and industries. As CTO Brett focuses Extropys “tribal knowledge” to define and refine our technology and business solutions; always staying ahead of the curve. His vision is centered on creating and delivering the most innovative technology solutions available and developing them into long term growth opportunities. Brett has extensive experience in delivering innovative solutions to Fortune 500 customers, transforming their businesses as a trusted partner. Additionally Brett has experience in developing and operating service provider organizations. Brett’s educational experience spans across the sciences, having attended Clarkson and the University of Buffalo studying physics, information and computer sciences. He also holds numerous certifications, including the industries highest networking certification, Cisco Certified Internetworking Expert, (CCIE #11918), and the most respected security certification, Certified Information Systems Security Professional (CISSP).

Do you know anyone at Extropy ?

Go here to read the rest:

Executive Team | http://www.extropy.com

Posted in Extropy | Comments Off on Executive Team | www.extropy.com

American Institute of Alternative Medicine

Posted: July 31, 2016 at 5:48 am

Diane Sater-Wee, BS LMT Chief Executive Officer

Diane is responsible for AIAM’s strategic direction and compliance with legal and accrediting standards. She has served on the National and State of Ohio Boards of the American Massage Therapy Association (AMTA), the Executive Committee for the National Council of Colleges of Acupuncture and Oriental Medicine, the founding board of the Ohio Council of Massage Therapy Schools, and on various committees for the State Medical Board of Ohio and the Asian Bodywork Therapy Association.

Diane worked as an Account Representative for five years and as an Engineer for another five years with IBM. Diane received her undergraduate degree from The Ohio State University College of Engineering and her massage diploma from the Central Ohio School of Massage. email

Helen co-founded AIAM with Diane in 1990. She is responsible for setting the schools administrative and financial objectives, policies and practices. She also directs the acquisition, development, implementation and operation support systems. In addition to her work at AIAM, Helen serves on the Accreditation Commission for Acupuncture and Oriental Medicine (ACAOM) site visit team for the evaluation of acupuncture schools across the country.

Helen serves on the Stonewall Columbus Board of Trustees and is on the Board of Directors for State of the Arts Productions. She previously served as President of the Pacific Association of Women Martial Artists. Helen has competed in both national and international martial arts competitions throughout her career and was an alternate in the 1988 Olympics. She competed on the U.S. Tae Kwon Do team in 1990, earning a silver medal in the World Cup in Madrid, Spain. Helen was inducted into the Bruce Lee Martial Arts Hall of Fame in 2015. email

Read the rest here:

American Institute of Alternative Medicine

Posted in Alternative Medicine | Comments Off on American Institute of Alternative Medicine

Technology News | Reuters.com

Posted: March 27, 2016 at 12:44 am

Verizon Communications Inc said an attacker had exploited a security vulnerability on its enterprise client portal to steal contact information of a number of customers.

26 Mar 2016

NEW YORK Apple Inc said the U.S. Justice Department’s new attempts to unlock an iPhone used by one of the San Bernardino shooters without the tech giant’s help could eliminate the government’s need for its assistance in a similar dispute in New York.

BOAO, China Ride hailing app company Uber Technologies Inc [UBER.UL] is generating more than $1 billion in profit a year in its top 30 cities globally, and partly using that money to bankroll its expansion in China, Chief Executive Travis Kalanick said in an interview.

25 Mar 2016

SHANGHAI China’s commerce ministry said on Friday it hoped telecom equipment maker ZTE Corp could be removed as soon as possible from a U.S. list of companies slapped with tough export restrictions this month.

24 Mar 2016

Netflix Inc said it had been lowering the quality of its video for customers watching its service on wireless networks such as AT&T and Verizon Communications for more than five years, The Wall Street Journal reported on Thursday.

24 Mar 2016

View original post here:

Technology News | Reuters.com

Posted in Technology | Comments Off on Technology News | Reuters.com

Space Foundation Statement on President's Proposed NASA Budget

Posted: February 3, 2015 at 6:49 pm

Washington, D.C.,(Feb. 2, 2015) — The Space Foundation today said it supports President Obama’s FY2016 budget request for the National Aeronautics and Space Administration (NASA). That request, released today, calls for a FY2016 top line budget of $18.5 billion for the nation’s space agency — a $519 million increase over what Congress approved for the current fiscal year.

“The President’s request is a move in the right direction,” said Space Foundation Chief Executive Officer Elliot Pulham.

“The U.S. investment in NASA is a strategic investment in the future — one that fuels our technology base, our global economic competitiveness, and our ability to lead international partnerships,” Pulham said.”In that context, we believe the NASA budget can, and should, continue to grow.The President’s FY2016 budget request preserves International Space Station operations through 2024, increases NASA science programs by $43 million to $5.29 billion, keeps the SLS-Orion program on track to provide capabilities for human exploration beyond low earth orbit, and preserves a space technology budget of $724.8 million.

“The proposed budget also includes a credible aeronautics program, funded at $571.4 million,” Pulham said, “and, very importantly, it keeps commercial crew transport programs on track with $1.2 billion in funding toward a competitive, two-supplier system that will return America to human spaceflight operations in just two years’ time.”

About the Space Foundation Founded in 1983, the Space Foundation is the foremost advocate for all sectors of space, and is a global, nonprofit leader in space awareness activities, educational programs and major industry events, including the annualSpace Symposium, in support of its mission “to advance space-related endeavors to inspire, enable and propel humanity.” Space Foundation World Headquarters in Colorado Springs, Colo., USA, has a publicDiscovery Center, includingEl Pomar Space Gallery,Northrop Grumman Science Center featuring Science On a Sphere and the Lockheed Martin Space Education Center.The Space Foundation has a field office in Houston, and conducts government affairs from its Washington, D.C., office.It annually publishesThe Space Report: The Authoritative Guide to Global Space Activity,andthrough itsSpace CertificationandSpace Technology Hall of Fame programs,recognizes space-basedinnovations that have been adapted to improve life on Earth. Visitwww.SpaceFoundation.org, follow us onFacebook,Instagram,LinkedIn,Pinterest,TwitterandYouTube,and read our e-newsletterSpace Watch.

# # #

Please follow SpaceRef on Twitter and Like us on Facebook.

Continued here:
Space Foundation Statement on President's Proposed NASA Budget

Posted in Space Station | Comments Off on Space Foundation Statement on President's Proposed NASA Budget

23andMe Gives Pfizer DNA Data as Startup Seeks Growth

Posted: January 12, 2015 at 8:48 pm

Jan. 12 (Bloomberg) — 23andMe Director of Business Development Emily Drabant Conley discusses her companys collaboration with Pfizer to help find new targets to treat disease and to design clinical trials. She speaks on “Bloomberg West.” (Source: Bloomberg)

23andMe Inc., the genetic-testing startup backed by Google Inc. (GOOG), is sharing DNA data on about 650,000 individuals with Pfizer Inc. (PFE), to help find new targets to treat disease and to design clinical trials.

The collaboration with Pfizer is the broadest announced so far in 23andMes ambitious plan to become a repository for humanitys genetic makeup, and to turn data gathered from $99 saliva tests sold to consumers into multimillion-dollar deals with drugmakers.

The agreement unveiled today gives the U.S.s largest drugmaker access to anonymous, aggregated information from consumers who bought 23andMes test over the past seven years to learn about their own genetic histories. It includes only people who agreed to let their data be used in research. Pfizer and 23andMe declined to give the deals value.

Related: 23andme Aims to End FDA Standoff This Year After Public Shaming

The Silicon Valley startup, named for the 23 pairs of chromosomes in human cells, is betting its growing troves of genetic data will prove essential to drug companies, medical researchers and even health and wellness companies.

Even as it seeks to expand its consumer tests around the world, the company is repairing relations with the U.S. Food and Drug Administration. An agency ruling in late 2013 left 23andMe unable to sell health analyses from the saliva tests.

Anne Wojcicki, co-founder and chief executive officer of 23andMe Inc., speaks during a Bloomberg Television interview in San Francisco, California, on Oct. 9, 2014. Close

Anne Wojcicki, co-founder and chief executive officer of 23andMe Inc., speaks during a… Read More

Close

See more here:
23andMe Gives Pfizer DNA Data as Startup Seeks Growth

Posted in DNA | Comments Off on 23andMe Gives Pfizer DNA Data as Startup Seeks Growth

Personal Genome Diagnostics, Inc. And Human Longevity, Inc …

Posted: at 8:47 pm

BALTIMORE and LA JOLLA, Calif., Jan. 12, 2015 /PRNewswire/ –Personal Genome Diagnostics, Inc. (PGDx), a provider of advanced cancer genome analysis and testing services, and Human Longevity, Inc. (HLI), the human health information technology and health care company, today announced that HLI will have access to PGDx’s cancer genomics solutions to expand its analysis of cancer genomes, including CancerSelect, PlasmaSelect, CancerXome, METDetect and CancerComplete. HLI has also licensed the PGDx Enterprise Solution platform, which is a turnkey solution that enables laboratories to conduct their own advanced cancer genomic testing using next-generation sequencing.

PGDx co-founder and Chief Medical Officer Luis Diaz, MD, noted, “As pioneers in the field of cancer genomics, we are delighted to be collaborating with HLI, a visionary company co-founded by genomics legend J. Craig Venter.” PGDx co-founder and Chief Scientific Officer Victor Velculescu, MD, PhD, added, “HLI’s commitment to changing the way medicine is practiced by systematically harnessing genomics data to address aging-associated diseases aligns well with our goal of transforming the treatment of cancer by enabling researchers, physicians and patients to use genomics data to advance and personalize cancer therapy.”

PGDx applies its advanced genomic methods to identify and characterize the unique genomic alterations in tumors using tissue and liquid biopsies from cancer patients. The ES platform utilizes PGDx’s proprietary bioinformatics software pipeline that provides industry-leading sensitivity and specificity, while maximizing accuracy in detecting multiple types of tumor-specific mutations. PGDx’s targeted gene panels focus on well-characterized genes that have been selected for their high biologic importance in cancer and their relevance to drug targets and pathways.

HLI is building the world’s largest and most comprehensive database of human genomic and phenotype data. The company has signed agreements with academic medical centers and large biotechnology companies to sequence and analyze human genomes, including those of cancer patients, to determine more precise treatments and more details about the specific tumor and cancer in that patient. The PGDx suite of solutions will enable even greater precision and detail for HLI’s customers and their patients.

As part of the agreement, HLI will perform sequencing and analysis for select PGDx customers and for their own research activities.

“Having access to PGDx’s capabilities, targeted cancer panels and Enterprise Solution platform for advanced cancer genomic testing is another important component to our already comprehensive and accurate database of human biological data,” said J. Craig Venter, PhD, HLI’s Co-founder, Chairman, and Chief Executive Officer. “We are excited to be partnering with PGDx and the extensive cancer genomics expertise and technology innovations developed by the world-class research team at PGDx.”

About Personal Genome DiagnosticsPersonal Genome Diagnostics (PGDx) provides advanced cancer genome analyses to oncologyresearchers, drug developers, clinicians and patients. The company uses advanced genomic methods and its deep expertise in cancer biology to identify and characterize the unique genomic alterations in tumors. PGDx’s proprietary methods for genome sequencing and analysis are complemented by its extensive experience in cancer genomics and clinical oncology. Co-founders Luis Diaz, MD, and Victor Velculescu, MD, PhD, are internationally recognized leaders in cancer genomics who have extensive experience in the practical application of advanced genomic technologies to research, drug development and clinical practice. PGDx’s CLIA-certified facility provides personalized cancer genome analyses to patients and their physicians. For more information, visit http://www.personalgenome.com.

About Human Longevity, Inc.HLI, a privately held company headquartered in San Diego, CA was founded in 2013 by pioneers in the fields of genomics and stem cell therapy. Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world’s most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline. HLI will be licensing access to its database, and developing new diagnostics and therapeutics as part of their product offerings. For more information please visitwww.humanlongevity.com

Contacts

PGDx Corporate: Antony Newton Chief Commercial Officer 443-602-8833 anewton@personalgenome.com

More:
Personal Genome Diagnostics, Inc. And Human Longevity, Inc …

Posted in Human Longevity | Comments Off on Personal Genome Diagnostics, Inc. And Human Longevity, Inc …

Personal Genome Diagnostics, Inc. And Human Longevity, Inc. Sign Cancer Genomics Agreement

Posted: at 8:47 pm

BALTIMORE and LA JOLLA, Calif., Jan. 12, 2015 /PRNewswire/ –Personal Genome Diagnostics, Inc. (PGDx), a provider of advanced cancer genome analysis and testing services, and Human Longevity, Inc. (HLI), the human health information technology and health care company, today announced that HLI will have access to PGDx’s cancer genomics solutions to expand its analysis of cancer genomes, including CancerSelect, PlasmaSelect, CancerXome, METDetect and CancerComplete. HLI has also licensed the PGDx Enterprise Solution platform, which is a turnkey solution that enables laboratories to conduct their own advanced cancer genomic testing using next-generation sequencing.

PGDx co-founder and Chief Medical Officer Luis Diaz, MD, noted, “As pioneers in the field of cancer genomics, we are delighted to be collaborating with HLI, a visionary company co-founded by genomics legend J. Craig Venter.” PGDx co-founder and Chief Scientific Officer Victor Velculescu, MD, PhD, added, “HLI’s commitment to changing the way medicine is practiced by systematically harnessing genomics data to address aging-associated diseases aligns well with our goal of transforming the treatment of cancer by enabling researchers, physicians and patients to use genomics data to advance and personalize cancer therapy.”

PGDx applies its advanced genomic methods to identify and characterize the unique genomic alterations in tumors using tissue and liquid biopsies from cancer patients. The ES platform utilizes PGDx’s proprietary bioinformatics software pipeline that provides industry-leading sensitivity and specificity, while maximizing accuracy in detecting multiple types of tumor-specific mutations. PGDx’s targeted gene panels focus on well-characterized genes that have been selected for their high biologic importance in cancer and their relevance to drug targets and pathways.

HLI is building the world’s largest and most comprehensive database of human genomic and phenotype data. The company has signed agreements with academic medical centers and large biotechnology companies to sequence and analyze human genomes, including those of cancer patients, to determine more precise treatments and more details about the specific tumor and cancer in that patient. The PGDx suite of solutions will enable even greater precision and detail for HLI’s customers and their patients.

As part of the agreement, HLI will perform sequencing and analysis for select PGDx customers and for their own research activities.

“Having access to PGDx’s capabilities, targeted cancer panels and Enterprise Solution platform for advanced cancer genomic testing is another important component to our already comprehensive and accurate database of human biological data,” said J. Craig Venter, PhD, HLI’s Co-founder, Chairman, and Chief Executive Officer. “We are excited to be partnering with PGDx and the extensive cancer genomics expertise and technology innovations developed by the world-class research team at PGDx.”

About Personal Genome DiagnosticsPersonal Genome Diagnostics (PGDx) provides advanced cancer genome analyses to oncologyresearchers, drug developers, clinicians and patients. The company uses advanced genomic methods and its deep expertise in cancer biology to identify and characterize the unique genomic alterations in tumors. PGDx’s proprietary methods for genome sequencing and analysis are complemented by its extensive experience in cancer genomics and clinical oncology. Co-founders Luis Diaz, MD, and Victor Velculescu, MD, PhD, are internationally recognized leaders in cancer genomics who have extensive experience in the practical application of advanced genomic technologies to research, drug development and clinical practice. PGDx’s CLIA-certified facility provides personalized cancer genome analyses to patients and their physicians. For more information, visit http://www.personalgenome.com.

About Human Longevity, Inc.HLI, a privately held company headquartered in San Diego, CA was founded in 2013 by pioneers in the fields of genomics and stem cell therapy. Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world’s most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline. HLI will be licensing access to its database, and developing new diagnostics and therapeutics as part of their product offerings. For more information please visitwww.humanlongevity.com

Contacts

PGDx Corporate: Antony Newton Chief Commercial Officer 443-602-8833 anewton@personalgenome.com

See the original post:
Personal Genome Diagnostics, Inc. And Human Longevity, Inc. Sign Cancer Genomics Agreement

Posted in Human Longevity | Comments Off on Personal Genome Diagnostics, Inc. And Human Longevity, Inc. Sign Cancer Genomics Agreement